Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis.

Maurizio ValerianiBeatrice DettiAndrei FodorSaverio CainiSimona BorghesiFabio TrippaLuca TriggianiAlessio BruniDonatella RussoSimonetta SaldiMario Di StasoGiulio FrancoliniAndrea LanciaLuca MarinelliNadia Di MuzioCynthia AristeiLorenzo LiviStefano Maria MagriniGianluca Ingrosso

Published in: La Radiologia medica (2021)

Our study shows that radiotherapy in oligoprogressive mCRPC is safe, is effective and seems to prolong the efficacy of ARTT in patients who otherwise would have gone systemic treatment switch, positively affecting disease progression. Prospective trials are needed.

Keyphrases

early stage
end stage renal disease
ejection fraction
newly diagnosed
radiation therapy
squamous cell carcinoma
locally advanced
chronic kidney disease
small cell lung cancer
radiation induced
prognostic factors